In vivo protection of activated Tyr22-dihydrofolate reductase gene-modified canine T lymphocytes from methotrexate.
about
In vivo protection of activated Tyr22-dihydrofolate reductase gene-modified canine T lymphocytes from methotrexate.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo protection of activate ...... lymphocytes from methotrexate.
@en
In vivo protection of activate ...... lymphocytes from methotrexate.
@nl
type
label
In vivo protection of activate ...... lymphocytes from methotrexate.
@en
In vivo protection of activate ...... lymphocytes from methotrexate.
@nl
prefLabel
In vivo protection of activate ...... lymphocytes from methotrexate.
@en
In vivo protection of activate ...... lymphocytes from methotrexate.
@nl
P2093
P2860
P356
P1476
In vivo protection of activate ...... lymphocytes from methotrexate
@en
P2093
Brian C Beard
Christina Ironside
Debra Swanson
Hans-Peter Kiem
Nathaniel P Williams
R Scott McIvor
P2860
P304
P356
10.1002/JGM.2713
P577
2013-06-01T00:00:00Z